Article: Short-Term Nicotinamide Riboside Supplementation Increases Muscle NAD+ Flux: Clinical Findings

Jan 25, 2021 Clinical Muscle Health

Short-Term Nicotinamide Riboside Supplementation Increases Muscle NAD+ Flux: Clinical Findings

Objectives

To assess the effects of NR supplementation on whole-body metabolism and exercise-induced mitochondrial signaling in the skeletal muscle of healthy adults.

Journal

The Journal of Physiology

Key Outcomes

NR supplementation did not alter NAD-sensitive signaling pathways in skeletal muscle and did not have any effect on skeletal muscle mitochondrial respiration nor whole-body metabolism.
Although NR did not increase skeletal muscle NAD+ levels, it increased markers of NAD flux, demonstrating the skeletal muscle bioavailability of NR supplementation.

Duration

1 week

Dose

1000 mg

Study Design

Randomized, double-blind, placebo-controlled, crossover study in 8 young, healthy, recreationally active men

See Published Study

Autoimmune Disease

Counteracting CD38-Induced NAD+ Depletion Reduces Multiple Organ Fibrosis: Preclinical Findings

SynopsisSystemic sclerosis (SSc) involves fibrosis in multiple organs, but its cause is not fully understood. NAD+ decline with age and disease, often due to increased CD38 activity (an NADase), ma...

Cellular Health

Equilibrative Nucleoside Transporters Transport Nicotinamide Riboside and Nicotinic Acid Riboside into Human Cells: Preclinical Findings

Synopsis Nicotinamide riboside (NR), a form of vitamin B3, is known to boost levels of NAD+, a vital molecule for energy production and cellular repair. However, how NR gets into cells has remaine...